With 1.15 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.78 million shares. During the session, the Insurance – Life company that operates in wider Financial sector, reached to the highest price of $38.055 whereas the lowest price it dropped to was $36.99. The 52-week range on CNO shows that it touched its highest point at $43.20 and its lowest point at $26.29 during that stretch. It currently has a 1-year price target of $42.67. With its current market cap of 3.72 billion, CNO has annualized dividend of $0.64 while the current yield stands at 1.72%. CNO paid its most recent dividend on 1741564800, while the ex-dividend date for that was 1741564800. Beta for the stock currently stands at 0.92.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CNO was down-trending over the past week, with a drop of -6.64%, but this was down by -11.58% over a month. Three-month performance dropped to -7.52% while six-month performance rose 6.82%. The stock gained 38.04% in the past year, while it has lost -0.24% so far this year. A look at the trailing 12-month EPS for CNO yields 2.86 with Next year EPS estimates of 4.22. For the next quarter, that number is 0.89. This implies an EPS growth rate of -4.27% for this year and 11.09% for next year. EPS is expected to grow by 5.71% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 7.48%.
Float and Shares Shorts:
At present, 99.89 million CNO shares are outstanding with a float of 97.29 million shares on hand for trading. On 2025-04-15, short shares totaled 2.43 million, which was 243.00002000000003 higher than short shares on 1741910400. In addition to Mr. Gary Chandru Bhojwani as the firm’s CEO & Director, Mr. Paul Harrington McDonough serves as its CFO & Executive VP.
Institutional Ownership:
Through their ownership of 0.97337997 of CNO’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CNO since 3 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CNO analysts setting a high price target of 49.0 and a low target of 40.0, the average target price over the next 12 months is 43.6. Based on these targets, CNO could surge 32.0% to reach the target high and rise by 7.76% to reach the target low. Reaching the average price target will result in a growth of 17.46% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $3.7633 being high and $3.71312 being low. For CNO, this leads to a yearly average estimate of $3.74323. Based on analyst estimates, the high estimate for the next quarter is $0.99 and the low estimate is $0.91. The average estimate for the next quarter is thus $0.95.
